"So yes, the hedged gold, is literally, losing RRL money and has been for a long time."
As much as I prefer to look on AIC instead of AISC I would not do that regarding hedging prices.
Argument for that thesis:
The exploration/non-sustaining cost are only undertaken/incurred because any additional production can be sold @ AUD 2.450. Those non-sustaining costs would be held much lower if the gold price were still at AUD 1.600/oz (because investment/Capex-decisions are naturally driven by the product price)
As per report on quarterly acivites (March-quarter), page 5, guidance for FY 20/21 regarding growth capital and exploration was 88-98 million.
Calculating coming from profit before tax Regis showed earnings of AUD 123 Mio. for July-December/2020 with 173k ounces sold and an average price realized of AUD 2.317/oz. So all costs in per half year report for FY2020/2021 they are showing earnings of 712 AUD/oz (and AIC of AUD 1.606).
- Forums
- ASX - By Stock
- Ann: Change to Hedging Structure
RRL
regis resources limited
Add to My Watchlist
2.23%
!
$4.39

"So yes, the hedged gold, is literally, losing RRL money and has...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.39 |
Change
-0.100(2.23%) |
Mkt cap ! $3.316B |
Open | High | Low | Value | Volume |
$4.47 | $4.53 | $4.37 | $16.81M | 3.793M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 51252 | $4.36 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.39 | 7201 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 51252 | 4.360 |
4 | 37004 | 4.350 |
2 | 24411 | 4.340 |
2 | 6157 | 4.310 |
5 | 37325 | 4.300 |
Price($) | Vol. | No. |
---|---|---|
4.390 | 7201 | 1 |
4.400 | 28087 | 1 |
4.410 | 38340 | 4 |
4.420 | 26563 | 3 |
4.430 | 15681 | 1 |
Last trade - 16.17pm 27/06/2025 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online